LifeVantage Corporation (LFVN) Earnings
LifeVantage Corporation is expected to report next earnings on September 3, 2026 (in NaN days), with a consensus EPS estimate of $0.15. LFVN has beaten EPS estimates in 4 of its last 11 reported quarters (average surprise -12.7% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 6, 2026 | $0.16 | $0.12 | -25.0% | $44M | -8.5% |
| Feb 4, 2026 | $0.22 | $0.15 | -31.8% | $49M | -5.6% |
| Nov 4, 2025 | $0.17 | $0.18 | +5.9% | $58M | +7.4% |
| Sep 4, 2025 | $0.17 | $0.17 | +0.0% | $55M | -4.9% |
| Feb 5, 2025 | $0.13 | $0.22 | +69.2% | $68M | +0.5% |
| May 2, 2024 | $0.16 | $0.21 | +31.2% | $48M | -5.3% |
| Jan 30, 2024 | $0.04 | $0.10 | +150.0% | $52M | -7.0% |
| Nov 9, 2023 | — | $0.13 | — | $51M | -76.6% |
| Aug 28, 2023 | $0.20 | $0.17 | -15.0% | $54M | +6.4% |
| May 4, 2023 | $0.15 | $0.08 | -46.7% | $54M | +5.5% |
| Feb 2, 2023 | $0.05 | $-0.07 | -240.0% | $54M | +4.9% |
| Nov 2, 2022 | $0.15 | $0.06 | -60.0% | $52M | +3.0% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q3 FY2026 · May 6, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
Michael Beindorf introduced himself, recognized Steve Fife's retirement. Talked about product portfolio including ProTandem family, TrueScience Liquid Collagen, etc. Mentioned Momentum Academy in Las Vegas, VIP bonus program. Invested in digital capabilities, e-commerce platform upgrade. Announced U.S. patent for Healthy Glow Essentials stack. Appointed Terrence Moorhead as next CEO.
Guidance
Now expect to end fiscal 2026 with revenue, adjusted EBITDA, and adjusted earnings per share close to the lower end of previously issued guidance range. Reflects GLP-1 market competitive dynamics and cost management while investing in strategic growth initiatives.
Segment performance
For the third quarter of fiscal 2026, net revenue was $43.7 million, down 25.2% from $58.4 million in the prior year. Americas region revenue decreased 28.9% to $34.3 million, Asia Pacific and Europe region decreased 7.7% to $9.4 million. Gross profit percentage was 79%, non-GAAP adjusted gross profit percentage 79.4%. Commissions and incentive expense as a percentage of revenue was 43.5%. Selling general and administrative expenses were 31.7% of revenue. GAAP operating income was $1.7 million, adjusted non-GAAP operating income $1.8 million. GAAP net income $1.4 million, adjusted non-GAAP net income $1.5 million.
Analyst Q&A
Q: Doug Lane asked about cash from operations, CapEx, share buyback, consultant count, new products.
A: Carl and Kristen responded regarding cash from operations expected similar in Q4, CapEx to be consistent, commitment to share buyback, efforts to address consultant count in Americas and plans for new products including annual convention in October with a science-backed product in the works